Stock Events

Stock Events

Carisma Therapeutics 

$0.03
114
+$0+2.73% Thursday 19:47

Statistics

Day High
0.04
Day Low
0.03
52W High
1.27
52W Low
0.03
Volume
22,217
Avg. Volume
111,540
Mkt Cap
1.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 23
$0.18
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.32
-0.24
-0.17
-0.09
Expected EPS
-0.1474
Actual EPS
N/A

Financials

-308.05%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
39.26MRevenue
-120.95MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CARM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap275.13M
Allogene Therapeutics is involved in the development of allogeneic CAR T therapies for cancer, similar to Carisma's focus on innovative cancer treatments.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is engaged in gene editing and CAR-T cell therapies, competing in the advanced therapy medicinal products (ATMPs) space like Carisma.
Novartis
NVS
Mkt Cap237.61B
Novartis is a major player in the CAR T-cell therapy market with approved products, representing significant competition for Carisma in terms of market share and innovation.
Precigen
PGEN
Mkt Cap1.46B
Precigen is a biotechnology company that develops CAR-T and other gene and cell therapies, competing in the same space as Carisma for novel cancer treatments.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics works on gene editing and cell therapy, including CAR-T therapies, making it a competitor in the field of genetic and cell-based cancer treatments.

About

Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human diseases. Carisma Therapeutics, Inc. has a strategic collaboration agreement with Moderna Inc. Carisma Therapeutics, Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was incorporated in 2016 and is based in Philadelphia, Pennsylvania.
Show more...
CEO
Mr. Steven Kelly
Employees
46
Country
US
ISIN
US14216R1014

Listings

OTC Link
US
CARM

0 Comments

Share your thoughts

FAQ

What is Carisma Therapeutics stock price today?▼
The current price of CARM is $0.03 USD — it has increased by +2.73% in the past 24 hours. Watch Carisma Therapeutics stock price performance more closely on the chart.
What is Carisma Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Carisma Therapeutics stocks are traded under the ticker CARM.
Is Carisma Therapeutics stock price growing?▼
CARM stock has risen by +4.31% compared to the previous week, the month change is a -18.31% fall, over the last year Carisma Therapeutics has showed a -82.31% decrease.
What is Carisma Therapeutics market cap?▼
Today Carisma Therapeutics has the market capitalization of 1.42M
When is the next Carisma Therapeutics earnings date?▼
Carisma Therapeutics is going to release the next earnings report on May 07, 2026.
What is Carisma Therapeutics revenue for the last year?▼
Carisma Therapeutics revenue for the last year amounts to 39.26M USD.
What is Carisma Therapeutics net income for the last year?▼
CARM net income for the last year is -120.95M USD.
Does Carisma Therapeutics pay dividends?▼
Yes, CARM dividends are paid en. The last dividend per share was 0.18 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Carisma Therapeutics have?▼
As of April 06, 2026, the company has 46 employees.
In which sector is Carisma Therapeutics located?▼
Carisma Therapeutics operates in the Health Care sector.
When did Carisma Therapeutics complete a stock split?▼
The last stock split for Carisma Therapeutics was on March 08, 2023 with a ratio of 2:1.
Where is Carisma Therapeutics headquartered?▼
Carisma Therapeutics is headquartered in Philadelphia, US.